WST raises full-year guidance after strong Q2
West Pharmaceutical’s Q2 revenue grew 13%, driven by HVP and GLP-1 demand, leading it to raise its full-year outlook.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.